21 reports of this reaction
3.0% of all NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE reports
#3 most reported adverse reaction
PAIN is the #3 most commonly reported adverse reaction for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, manufactured by Amneal Pharmaceuticals NY LLC. There are 21 FDA adverse event reports linking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE to PAIN. This represents approximately 3.0% of all 690 adverse event reports for this drug.
Patients taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE who experience pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PAIN is a less commonly reported adverse event for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, but still significant enough to appear in the safety profile.
In addition to pain, the following adverse reactions have been reported for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE:
The following drugs have also been linked to pain in FDA adverse event reports:
PAIN has been reported as an adverse event in 21 FDA reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PAIN accounts for approximately 3.0% of all adverse event reports for NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, making it one of the most commonly reported side effect.
If you experience pain while taking NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.